Search Results - "Ferreira, Aline F."

Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator by Ferreira, Aline F, Calin, George A, Picanço-Castro, Virgínia, Kashima, Simone, Covas, Dimas T, de Castro, Fabiola A

“…Although hematopoietic stem cell (HSC) therapy for hematological diseases can lead to a good outcome from the clinical point of view, the limited number of…”
Get full text

Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis by Tognon, Raquel, Gasparotto, Elainy P L, Neves, Renata P, Nunes, Natália S, Ferreira, Aline F, Palma, Patrícia V B, Kashima, Simone, Covas, Dimas T, Santana, Mary, Souto, Elizabeth X, Zanichelli, Maria Aparecida, Simões, Belinda P, de Souza, Ana Maria, Castro, Fabíola A

“…Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF) are Chronic Myeloproliferative Neoplasms (MPN) characterized by clonal…”
Get full text

Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia by Borges, Camilla de S., Ferreira, Aline F., Almeida, Vitor H., Gomes, Fausto G., Berzoti-Coelho, Maria Gabriela, Cacemiro, Maira da Costa, Nunes, Natalia S., Figueiredo-Pontes, Lorena L., Simões, Belinda P., Castro, Fabíola A., Monteiro, Robson Q.

“…•Protease-activated receptor 1 (PAR1) is a G protein-coupled receptor that is overexpressed in the blast crisis of chronic myeloid leukemia (CML).•CML cell…”
Get full text

Capillary electrophoresis method for plasmatic determination of imatinib mesylate in chronic myeloid leukemia patients by Ajimura, Tatiana O., Borges, Keyller B., Ferreira, Aline F., de Castro, Fabíola A., de Gaitani, Cristiane M.

“…Imatinib (IMAT) is a tyrosine kinase inhibitor that has been used for the treatment of chronic myeloid leukemia (CML). Despite the efficacy of IMAT therapy,…”
Get full text

Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias by Veiga, Camilla de S.B., Carneiro-Lobo, Tatiana C., Coelho, Cláudia J.B.P., Carvalho, Silvia M.F., Maia, Raquel C., Vasconcelos, Flávia C., Abdelhay, Eliana, Mencalha, André L., Ferreira, Aline F., Castro, Fabíola A., Monteiro, Robson Q.

“…Protease-activated receptor 1 (PAR-1) is a G-protein-coupled receptor that is overexpressed in solid tumors, being associated with several pro-tumoral…”
Get full text